PRMT5 thus appears to regulate splicing in cancer stem cells in a tissue-dependent manner, with BCSCs potentially reliant upon a higher fidelity of DNA repair transcript splicing to maintain genome stability, longevity, and chemoresistance compared to GSCs. This evidence concerns the gene PRMT5 and cancer.